524731 JENBURPH

Jenburkt Pharmaceuticals Share PriceJenburkt Pharmaceuticals

₹676.25
4.5 (0.67%)
As on 29 November, 2023 | 01:17 BSE: 524731 NSE: JENBURPHISIN: INE354A01013

Jenburkt Pharmaceuticals Performance

Day Range

  • Low
  • High
676.25

52 Week Range

  • Low
  • High
676.25
  • Open Price
  • Previous Close
  • Volume

Start SIP in Jenburkt Pharmaceuticals

Start SIP

Jenburkt Pharmaceuticals Share Price

  • Over 1 Month 7.01%
  • Over 3 Month -4.34%
  • Over 6 Month -12.57%
  • Over 1 Year 14.09%

Jenburkt Pharmaceuticals Key Statistics

Jenburkt Pharmaceuticals Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 38293535363128
Operating Expenses Qtr Cr 29222828272424
Operating Profit Qtr Cr 9777975
Depreciation Qtr Cr 1111111
Interest Qtr Cr 0000000
Tax Qtr Cr 2222222
Net Profit Qtr Cr 7565763
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 142129
Operating Expenses Annual Cr 10697
Operating Profit Annual in Cr 3027
Depreciation Cr 22
Interest Annual Cr 00
Tax Annual Cr 88
Net Profit Annual Cr 2522
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 9
Cash from Investing Activity Annual Cr -1
Cash from Financing Annual Activity Cr -6
Net Cash Flow Annual Cr 3
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 122117
Fixed Assets Annual Cr 1112
Total Non Current Assets Annual Cr 6167
Total Current Assets Annual Cr 8176
Total Assets Annual Cr 142143
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 277256
ROE Annual % 2019
ROCE Annual % 2625
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 2626
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual --
EBDIT Annual Margin %

Jenburkt Pharmaceuticals Technicals

EMA & SMA

Current Price
₹676.25
4.5 (0.67%)
pointer
  • Bullish Moving Average
  • ___
  • 9
  • Bearish Moving Average
  • ___
  • 7
  • 20 Day
  • ₹670.02
  • 50 Day
  • ₹674.06
  • 100 Day
  • ₹684.46
  • 200 Day
  • ₹678.93
  • 20 Day
  • ₹662.9
  • 50 Day
  • ₹670.27
  • 100 Day
  • ₹699.75
  • 200 Day
  • ₹694.73

Jenburkt Pharmaceuticals Resistance and Support

PIVOT
₹674.65
Resistance
First Resistance ₹688.3
Second Resistance ₹700.35
Third Resistance ₹714
RSI 54.16
MFI 74.86
MACD Single Line 3
MACD 4.67
Support
First Resistance ₹662.6
Second Resistance ₹648.96
Third Resistance ₹636.9

Jenburkt Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 2,488 231,210 92.93
Week 2,168 196,703 90.73
1 Month 2,620 223,268 85.22
6 Month 2,408 197,825 82.17

Jenburkt Pharmaceuticals Result Highlights

Jenburkt Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Jenburkt Pharmaceuticals Corporate Action

Date Purpose Remarks
2023-11-07 Quarterly Results
2023-08-08 Quarterly Results
2023-05-23 Audited Results, Dividend & A.G.M.
2023-02-07 Quarterly Results
2022-12-01 Buy Back of Shares

Jenburkt Pharmaceuticals FAQs

What is Share Price of Jenburkt Pharmaceuticals ?

Jenburkt Pharmaceuticals share price is ₹676 As on 29 November, 2023 | 01:03

What is the Market Cap of Jenburkt Pharmaceuticals ?

The Market Cap of Jenburkt Pharmaceuticals is ₹298.4 Cr As on 29 November, 2023 | 01:03

What is the P/E ratio of Jenburkt Pharmaceuticals ?

The P/E ratio of Jenburkt Pharmaceuticals is 12.2 As on 29 November, 2023 | 01:03

What is the PB ratio of Jenburkt Pharmaceuticals ?

The PB ratio of Jenburkt Pharmaceuticals is 2.4 As on 29 November, 2023 | 01:03

Q2FY23